A mitotic NADPH upsurge promotes chromosome segregation and tumour progression in aneuploid cancer cells
A mitotic NADPH upsurge promotes chromosome segregation and tumour progression in aneuploid cancer cells
复制标题
DOI:
10.1038/s42255-023-00832-9
复制
发表时间:
2023-06
影响因子:
20.8
通讯作者:
Aoxing Cheng;Tianbing Xu;Weiyi You;Ting Wang;D. Zhang;Huimin Guo;Haiyan Zhang;Xin Pan
中科院分区:
文献类型:
--
作者:
Aoxing Cheng;Tianbing Xu;Weiyi You;Ting Wang;D. Zhang;Huimin Guo;Haiyan Zhang;Xin Pan
Redox metabolites have been observed to fluctuate through the cell cycle in cancer cells, but the functional impacts of such metabolic oscillations remain unknown. Here, we uncover a mitosis-specific nicotinamide adenine dinucleotide phosphate (NADPH) upsurge that is essential for tumour progression. Specifically, NADPH is produced by glucose 6-phosphate dehydrogenase (G6PD) upon mitotic entry, which neutralizes elevated reactive oxygen species (ROS) and prevents ROS-mediated inactivation of mitotic kinases and chromosome missegregation. Mitotic activation of G6PD depends on the phosphorylation of its co-chaperone protein BAG3 at threonine 285, which results in dissociation of inhibitory BAG3. Blocking BAG3T285phosphorylation induces tumour suppression. A mitotic NADPH upsurge is present in aneuploid cancer cells with high levels of ROS, while nearly unobservable in near-diploid cancer cells. High BAG3T285phosphorylation is associated with worse prognosis in a cohort of patients with microsatellite-stable colorectal cancer. Our study reveals that aneuploid cancer cells with high levels of ROS depend on a G6PD-mediated NADPH upsurge in mitosis to protect them from ROS-induced chromosome missegregation.